82 related articles for article (PubMed ID: 25354243)
1. C-peptide concentration, mortality and vascular complications in people with Type 2 diabetes. The Skaraborg Diabetes Register.
Pikkemaat M; Melander O; Mölstad S; Garberg G; Boström KB
Diabet Med; 2015 Jan; 32(1):85-9. PubMed ID: 25354243
[TBL] [Abstract][Full Text] [Related]
2. C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register.
Pikkemaat M; Andersson T; Melander O; Chalmers J; Rådholm K; Bengtsson Boström K
Diabetes Res Clin Pract; 2019 Apr; 150():174-183. PubMed ID: 30878389
[TBL] [Abstract][Full Text] [Related]
3. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up.
Bo S; Gentile L; Castiglione A; Prandi V; Canil S; Ghigo E; Ciccone G
Eur J Endocrinol; 2012 Aug; 167(2):173-80. PubMed ID: 22577110
[TBL] [Abstract][Full Text] [Related]
4. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
Rawshani A; Rawshani A; Franzén S; Eliasson B; Svensson AM; Miftaraj M; McGuire DK; Sattar N; Rosengren A; Gudbjörnsdottir S
N Engl J Med; 2017 Apr; 376(15):1407-1418. PubMed ID: 28402770
[TBL] [Abstract][Full Text] [Related]
5. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
6. Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register.
Zethelius B; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Cederholm J;
Eur J Prev Cardiol; 2014 Feb; 21(2):244-51. PubMed ID: 24227183
[TBL] [Abstract][Full Text] [Related]
7. Relation of ocular and systemic factors to survival in diabetes.
Klein R; Moss SE; Klein BE; DeMets DL
Arch Intern Med; 1989 Feb; 149(2):266-72. PubMed ID: 2916872
[TBL] [Abstract][Full Text] [Related]
8. Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register.
Pikkemaat M; Melander O; Hjerpe P; Bengtsson Boström K
J Diabetes Complications; 2017 May; 31(5):854-858. PubMed ID: 28319005
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
[TBL] [Abstract][Full Text] [Related]
10. Long-term mortality and retinopathy in type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
[TBL] [Abstract][Full Text] [Related]
11. Impaired glucose metabolism in colorectal cancer.
Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
[TBL] [Abstract][Full Text] [Related]
12. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
Svensson MK; Cederholm J; Eliasson B; Zethelius B; Gudbjörnsdottir S;
Diab Vasc Dis Res; 2013 Nov; 10(6):520-9. PubMed ID: 24002670
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
Linnemann B; Voigt W; Nobel W; Janka HU
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
[TBL] [Abstract][Full Text] [Related]
15. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
Myhill P; Davis WA; Bruce DG; Mackay IR; Zimmet P; Davis TM
Diabet Med; 2008 Oct; 25(10):1245-50. PubMed ID: 19046207
[TBL] [Abstract][Full Text] [Related]
16. A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR).
Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Gudbjörnsdottir S;
Diabet Med; 2011 Oct; 28(10):1213-20. PubMed ID: 21627687
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
18. Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: a 10-year observation study.
Lövestam-Adrian M; Hansson-Lundblad C; Torffvit O
Diabetes Res Clin Pract; 2007 Jul; 77(1):141-7. PubMed ID: 17178168
[TBL] [Abstract][Full Text] [Related]
19. Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients.
Bodegard J; Sundström J; Svennblad B; Östgren CJ; Nilsson PM; Johansson G
Diabetes Metab; 2013 Sep; 39(4):306-13. PubMed ID: 23871502
[TBL] [Abstract][Full Text] [Related]
20. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study.
Cikamatana L; Mitchell P; Rochtchina E; Foran S; Wang JJ
Eye (Lond); 2007 Apr; 21(4):465-71. PubMed ID: 17318200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
